Bionabu Launches Secure Collaboration Platform for Health and Life Sciences Professionals to Network

Bionabu Launches Secure Collaboration Platform for Health and Life Sciences Professionals to Network

Published on 01/10/2021
Bionabu Launches Secure Collaboration Platform for Health and Life Sciences Professionals to Network

London, England, October 1st, 2021: Bionabu™ is proud to announce the upcoming launch of a first of its kind, secure collaboration platform for healthcare and life sciences professionals and entrepreneurs that rolls peer-to-peer learning, freelancer platforms, and master classes into one easy-to-use website built for collaboration and openness, offering bold solutions to the problems facing the healthcare industry worldwide.

In response to closed ecosystems, a lack of access to quality information, delays, and misinformation, Bionabu created its platform as an open-source medium for peer-to-peer generated content that will drive healthcare innovation forward faster. Bionabu was created by health-industry professionals for health-industry professionals, and it boasts an impressive user-interface and easy-to-use search functions to filter for niche expertises and interests.

Through advanced filters, question categories, instant messaging, and community forums, users are able to search for answers,  collaborate and find experts in healthcare, life sciences, law, technology, and finance. Bionabu allows users to filter by industry, area, keywords and interests, allowing professionals to easily connect with experts who will help solve problems, move ideas forward, and work together in an open environment.

Bionabu also offers master classes and virtual conferences, as well as live chat features, mentoring support, and networking boards, so professionals can meet and learn from peers and entrepreneurs.

“The healthcare and pharmaceutical industries are not easy to navigate. When I worked in the pharmaceutical industry, many answers I received were poor quality or grounded on false claims,” said Ina Burgstaller, founder and CEO of Bionabu. “Though the digital health market is rapidly growing, 90 percent of digital health startups fail in their first five years. This is in part due to their lack of expert resources.”

Bionabu combines advanced technology and industry-specific memberships to help facilitate change, exchange of ideas, and connection in an often disconnected industry. By creating a space for healthcare professionals to collaborate and innovate in an environment that is often secretive and hard to navigate, Bionabu is a hub for success, solving problems, and helping healthcare worldwide.

“Digital technology has the capacity to benefit healthcare in many ways,” Burgstaller said. “We can improve the standard of patient care, boost efficiency and productivity, and minimize error. As it stands, underprivileged stakeholders don’t always have access to shared data and new information. We want to bring everyone together - different professions, different departments, and different institutions- to solve problems and speed up access to quality information through collaboration and free transfer of ideas.”

About Bionabu

Bionabu is a digital platform created to strengthen close collaboration among all digital health stakeholders to positively affect healthcare innovation and digital healthcare. Bionabu seamlessly connects and shares knowledge among users, allowing industry professionals to network and collaborate to build the most promising and exciting digital healthcare innovations and find answers through advanced search functions, instant messaging, and forums, as well as master classes and mentoring opportunities.

With a TAM of £125 billion and a SOM of £20 million, Bionabu is poised for tremendous growth in its market. Pre-launch sign-up is open now, with Bionabu’s full launch scheduled for 19th October, 2021. Bionabu has selected eight partner organizations that enrolled in the pilot programme.

Bionabu plans to build in more AI technology and customizable features for its members. Bionabu has a pre-money valuation cap of £1,5 million, with the intention to achieve worldwide reach.

Our Valued Sponsors & Partners